annual CFO:
$171.95M+$60.87M(+54.79%)Summary
- As of today (May 24, 2025), SUPN annual cash flow from operations is $171.95 million, with the most recent change of +$60.87 million (+54.79%) on December 31, 2024.
- During the last 3 years, SUPN annual CFO has risen by +$44.82 million (+35.26%).
- SUPN annual CFO is now at all-time high.
Performance
SUPN Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$30.60M-$13.81M(-31.09%)Summary
- As of today (May 24, 2025), SUPN quarterly cash flow from operations is $30.60 million, with the most recent change of -$13.81 million (-31.09%) on March 31, 2025.
- Over the past year, SUPN quarterly CFO has dropped by -$7.80 million (-20.32%).
- SUPN quarterly CFO is now -66.72% below its all-time high of $91.95 million, reached on June 30, 2020.
Performance
SUPN quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$164.15M-$7.80M(-4.54%)Summary
- As of today (May 24, 2025), SUPN TTM cash flow from operations is $164.15 million, with the most recent change of -$7.80 million (-4.54%) on March 31, 2025.
- Over the past year, SUPN TTM CFO has increased by +$63.79 million (+63.56%).
- SUPN TTM CFO is now -9.96% below its all-time high of $182.32 million, reached on June 30, 2020.
Performance
SUPN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SUPN Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +54.8% | -20.3% | +63.6% |
| 3 y3 years | +35.3% | +611.3% | +72.4% |
| 5 y5 years | +20.1% | +243.2% | +37.9% |
SUPN Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +54.8% | -57.0% | +262.1% | -4.8% | +129.1% |
| 5 y | 5-year | at high | +54.8% | -66.7% | +262.1% | -10.0% | +129.1% |
| alltime | all time | at high | +396.7% | -66.7% | +260.2% | -10.0% | +353.8% |
SUPN Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $30.60M(-31.1%) | $164.15M(-4.5%) |
| Dec 2024 | $171.95M(+54.8%) | $44.41M(-17.0%) | $171.95M(-0.3%) |
| Sep 2024 | - | $53.52M(+50.2%) | $172.50M(+11.4%) |
| Jun 2024 | - | $35.62M(-7.2%) | $154.86M(+54.3%) |
| Mar 2024 | - | $38.40M(-14.6%) | $100.36M(-9.7%) |
| Dec 2023 | $111.08M(-4.9%) | $44.96M(+25.3%) | $111.08M(+18.6%) |
| Sep 2023 | - | $35.88M(-290.1%) | $93.69M(+30.7%) |
| Jun 2023 | - | -$18.87M(-138.4%) | $71.66M(-55.7%) |
| Mar 2023 | - | $49.13M(+78.2%) | $161.65M(+38.4%) |
| Dec 2022 | $116.83M(-8.1%) | $27.56M(+99.1%) | $116.83M(-15.4%) |
| Sep 2022 | - | $13.84M(-80.5%) | $138.03M(+14.9%) |
| Jun 2022 | - | $71.12M(+1553.2%) | $120.07M(+26.1%) |
| Mar 2022 | - | $4.30M(-91.2%) | $95.23M(-25.1%) |
| Dec 2021 | $127.13M(-8.1%) | $48.76M(-1286.4%) | $127.13M(+15.3%) |
| Sep 2021 | - | -$4.11M(-108.9%) | $110.30M(-8.1%) |
| Jun 2021 | - | $46.27M(+27.8%) | $120.01M(-27.6%) |
| Mar 2021 | - | $36.20M(+13.4%) | $165.68M(+19.7%) |
| Dec 2020 | $138.40M(-3.3%) | $31.93M(+470.3%) | $138.40M(-7.9%) |
| Sep 2020 | - | $5.60M(-93.9%) | $150.26M(-17.6%) |
| Jun 2020 | - | $91.95M(+931.3%) | $182.32M(+53.1%) |
| Mar 2020 | - | $8.92M(-79.6%) | $119.05M(-16.8%) |
| Dec 2019 | $143.13M(+11.0%) | $43.79M(+16.3%) | $143.13M(+8.3%) |
| Sep 2019 | - | $37.66M(+31.3%) | $132.19M(-15.8%) |
| Jun 2019 | - | $28.69M(-13.1%) | $156.98M(+16.4%) |
| Mar 2019 | - | $32.99M(+0.4%) | $134.85M(+4.5%) |
| Dec 2018 | $128.99M(+12.5%) | $32.85M(-47.4%) | $128.99M(-2.6%) |
| Sep 2018 | - | $62.45M(+852.5%) | $132.47M(+21.5%) |
| Jun 2018 | - | $6.56M(-75.8%) | $109.03M(-15.1%) |
| Mar 2018 | - | $27.13M(-25.3%) | $128.41M(+12.0%) |
| Dec 2017 | $114.64M | $36.34M(-6.8%) | $114.64M(+11.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $39.01M(+50.4%) | $103.24M(+11.6%) |
| Jun 2017 | - | $25.94M(+94.2%) | $92.48M(+11.0%) |
| Mar 2017 | - | $13.36M(-46.4%) | $83.31M(+24.7%) |
| Dec 2016 | $66.81M(+93.5%) | $24.94M(-11.7%) | $66.81M(+8.1%) |
| Sep 2016 | - | $28.24M(+68.3%) | $61.80M(+74.3%) |
| Jun 2016 | - | $16.78M(-634.0%) | $35.45M(+12.0%) |
| Mar 2016 | - | -$3.14M(-115.8%) | $31.65M(-8.3%) |
| Dec 2015 | $34.52M(-240.9%) | $19.93M(+957.1%) | $34.52M(+65.5%) |
| Sep 2015 | - | $1.89M(-85.5%) | $20.86M(+46.3%) |
| Jun 2015 | - | $12.98M(-4997.0%) | $14.26M(-352.1%) |
| Mar 2015 | - | -$265.00K(-104.2%) | -$5.66M(-76.9%) |
| Dec 2014 | -$24.50M(-57.7%) | $6.26M(-232.9%) | -$24.50M(-39.0%) |
| Sep 2014 | - | -$4.71M(-32.1%) | -$40.18M(-21.2%) |
| Jun 2014 | - | -$6.94M(-63.7%) | -$51.02M(-14.7%) |
| Mar 2014 | - | -$19.10M(+102.8%) | -$59.83M(+3.2%) |
| Dec 2013 | -$57.95M(+22.8%) | -$9.42M(-39.4%) | -$57.95M(-10.4%) |
| Sep 2013 | - | -$15.55M(-1.3%) | -$64.67M(+7.0%) |
| Jun 2013 | - | -$15.76M(-8.5%) | -$60.42M(+11.2%) |
| Mar 2013 | - | -$17.22M(+6.7%) | -$54.35M(+15.2%) |
| Dec 2012 | -$47.20M(+30.4%) | -$16.14M(+42.8%) | -$47.20M(+20.0%) |
| Sep 2012 | - | -$11.30M(+16.6%) | -$39.32M(+5.9%) |
| Jun 2012 | - | -$9.69M(-3.8%) | -$37.12M(+1.8%) |
| Mar 2012 | - | -$10.07M(+21.9%) | -$36.45M(+0.7%) |
| Dec 2011 | -$36.19M(+11.2%) | -$8.26M(-9.3%) | -$36.19M(+29.6%) |
| Sep 2011 | - | -$9.10M(+0.9%) | -$27.93M(+48.4%) |
| Jun 2011 | - | -$9.02M(-7.9%) | -$18.82M(+92.1%) |
| Mar 2011 | - | -$9.80M | -$9.80M |
| Dec 2010 | -$32.54M(-1335.5%) | - | - |
| Dec 2009 | $2.63M(-108.9%) | - | - |
| Dec 2008 | -$29.65M(+112.1%) | - | - |
| Dec 2007 | -$13.98M | - | - |
FAQ
- What is Supernus Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual CFO year-on-year change?
- What is Supernus Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly CFO year-on-year change?
- What is Supernus Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals TTM CFO year-on-year change?
What is Supernus Pharmaceuticals annual cash flow from operations?
The current annual CFO of SUPN is $171.95M
What is the all time high annual CFO for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual cash flow from operations is $171.95M
What is Supernus Pharmaceuticals annual CFO year-on-year change?
Over the past year, SUPN annual cash flow from operations has changed by +$60.87M (+54.79%)
What is Supernus Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of SUPN is $30.60M
What is the all time high quarterly CFO for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly cash flow from operations is $91.95M
What is Supernus Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, SUPN quarterly cash flow from operations has changed by -$7.80M (-20.32%)
What is Supernus Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of SUPN is $164.15M
What is the all time high TTM CFO for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high TTM cash flow from operations is $182.32M
What is Supernus Pharmaceuticals TTM CFO year-on-year change?
Over the past year, SUPN TTM cash flow from operations has changed by +$63.79M (+63.56%)